Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
about
Cholinesterase inhibitors for rarer dementias associated with neurological conditionsPharmacological treatment for memory disorder in multiple sclerosisEpstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapyImpact of Pharmacotherapy on Cognitive Dysfunction in Patients with Multiple Sclerosis.Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.
P2860
Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients.
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Randomised multicentre trial o ...... d multiple sclerosis patients.
@ast
Randomised multicentre trial o ...... d multiple sclerosis patients.
@en
Randomised multicentre trial o ...... d multiple sclerosis patients.
@nl
type
label
Randomised multicentre trial o ...... d multiple sclerosis patients.
@ast
Randomised multicentre trial o ...... d multiple sclerosis patients.
@en
Randomised multicentre trial o ...... d multiple sclerosis patients.
@nl
prefLabel
Randomised multicentre trial o ...... d multiple sclerosis patients.
@ast
Randomised multicentre trial o ...... d multiple sclerosis patients.
@en
Randomised multicentre trial o ...... d multiple sclerosis patients.
@nl
P2093
P2860
P356
P1476
Randomised multicentre trial o ...... d multiple sclerosis patients.
@en
P2093
M Meergans
We Hofmann
P2860
P304
P356
10.1177/1352458512463481
P577
2012-10-15T00:00:00Z